Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal-Reference-Cited by-同舟云学术

Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal

Published:2019-03 Issue:3 Volume:25 Page:570-576
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Li Ang^ORCID,Wu Qian,Davis Chris,Kirtane Kedar S.,Pham Phuqui D.,Sorror Mohamed L.,Lee Stephanie J.^ORCID,Gopal Ajay K.,Dong Jing-Fei,Garcia David A.,Weiss Noel S.,R. Hingorani Sangeeta

Funder

National Heart, Lung, and Blood Institute

National Cancer Institute

National Institutes of Health

Patient Centered Outcomes Research Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference27 articles.

1. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury;Jodele;Blood Rev,2015

2. Transplant-associated thrombotic microangiopathy: opening Pandora's box;Gavriilaki;Bone Marrow Transplant,2017

3. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation;Powles;Lancet,1980

4. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma;George;Transfusion,2004

5. Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: the incidence is not reduced;Shimoni;Biol Blood Marrow Transplant,2004

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic Microangiopathy;Transplantation and Cellular Therapy;2024-09

2. Thrombotic complications after hematopoietic stem cell transplantation and other cellular therapies;Thrombosis Update;2024-09

3. Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children;Transplantation and Cellular Therapy;2024-09

4. Development and implementation of evidence-based, nurse-leading early warning model and healthcare quality improvement project for transplant-associated thrombotic microangiopathy: a mixed-methods, before-and-after study;BMC Nursing;2024-08-07

5. Transplant-associated thrombotic microangiopathy in pediatrics: incidence, risk factors, therapeutic options, and outcome based on data from a single center;Frontiers in Oncology;2024-07-10